Biomet Sale Completed
Biomet announced yesterday that a private consortium has completed its eleven-point-four billion-dollar buyout of the Warsaw orthopedics manufacturer. Biomet’s stock has now stopped trading on the Nasdaq exchange. The company’s new owners plan to keep its headquarters in Warsaw.


0 Comments:
Post a Comment
<< News Home Page